Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Wilcoxon Signed-Ranks Test for Median of Single Population01:14

Wilcoxon Signed-Ranks Test for Median of Single Population

129
The Wilcoxon signed-rank test for the median of a single population is a nonparametric test used to evaluate whether the median of a population differs from a specified value. Unlike parametric tests, it does not require data to follow a normal distribution, making it suitable for non-normal or small samples. The test begins by calculating the difference (d) between each observation and the hypothesized median. The absolute values of these differences are ranked in ascending order, with ties...
129
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

498
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
498
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

137
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
137
Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

194
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
194
Median01:08

Median

18.5K
Besides mean, the median is a widely used measure of central tendency. Typically, median is defined as the central or middle value of a data set, measured by arranging the data elements in an increasing or decreasing order. Since this middle value is not affected by the precise numerical values of the outliers or fluctuations, it is insensitive to them. Hence, in cases where a data set may have outliers or the extreme values are not known, the median is a better measure of the central tendency...
18.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endoplasmic reticulum stress in antitumor immunity and immunotherapy resistance: mechanisms and therapeutic implications.

Molecular cancer·2026
Same author

Retraction notice to "Liposomal honokiol promotes hair growth via activating Wnt3a/β-catenin signaling pathway and down regulating TGF-β1 in C57BL/6N mice" [Biomedicine & Pharmacotherapy 141 (2021) 111793].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Electrospun Flexible Ceramic Nanofibers: Toward High-Performance Materials for Multifunctional Applications.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Randomized Trial of Adjunctive Prednisolone for Kawasaki Disease.

The New England journal of medicine·2026
Same author

Performance Enhancement of Amorphous Soft Magnetic Composites by Synergistic Warm Compaction and Fine FeNi Powders Addition.

Materials (Basel, Switzerland)·2026
Same author

Per- and polyfluoroalkyl substances and cardiovascular disease: A mechanistic and epidemiological synthesis.

Ecotoxicology and environmental safety·2026

Related Experiment Video

Updated: Jul 1, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K

High-dimensional generalized median adaptive lasso with application to omics data.

Yahang Liu1, Qian Gao2,3, Kecheng Wei1

  • 1Department of Biostatistics, School of Public Health, Fudan University, Shanghai, China.

Briefings in Bioinformatics
|March 4, 2024
PubMed
Summary

The generalized median adaptive lasso (GMAL) method accurately selects variables and estimates causal effects, even with skewed outcome data. This approach improves upon existing methods for high-dimensional datasets, particularly in real-world applications.

Keywords:
causal inferenceobservational studiespropensity scorevariable selection

More Related Videos

Assisted Selection of Biomarkers by Linear Discriminant Analysis Effect Size LEfSe in Microbiome Data
04:57

Assisted Selection of Biomarkers by Linear Discriminant Analysis Effect Size LEfSe in Microbiome Data

Published on: May 16, 2022

15.8K
Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

3.7K

Related Experiment Videos

Last Updated: Jul 1, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K
Assisted Selection of Biomarkers by Linear Discriminant Analysis Effect Size LEfSe in Microbiome Data
04:57

Assisted Selection of Biomarkers by Linear Discriminant Analysis Effect Size LEfSe in Microbiome Data

Published on: May 16, 2022

15.8K
Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

3.7K

Area of Science:

  • Statistics
  • Biostatistics
  • Genomics

Background:

  • High-dimensional data analysis presents challenges in variable selection for causal inference.
  • Skewed outcome distributions can compromise the accuracy of traditional causal effect estimation methods.
  • Accurate covariate selection is crucial for reliable causal inference.

Purpose of the Study:

  • To introduce a novel method, the generalized median adaptive lasso (GMAL), for robust variable selection in causal inference.
  • To address the challenges posed by skewed outcome distributions in high-dimensional data.
  • To improve the accuracy of causal effect estimation under skewed data conditions.

Main Methods:

  • Developed the generalized median adaptive lasso (GMAL) for covariate selection.
  • Utilized a linear median regression model for constructing penalty weights within GMAL.
  • Evaluated GMAL's performance through simulations and application to a real-world dataset.

Main Results:

  • GMAL demonstrated comparable variable selection performance to existing methods with symmetric outcome distributions.
  • GMAL showed superior performance in variable selection when outcome distributions were skewed.
  • GMAL consistently outperformed existing methods in causal effect estimation, evidenced by lower root-mean-square error.

Conclusions:

  • GMAL effectively handles skewed outcome distributions, ensuring accurate variable selection and causal effect estimation.
  • The proposed method offers a significant advancement for causal inference in high-dimensional settings with non-normally distributed outcomes.
  • GMAL was applied to a DNA methylation dataset to explore the relationship between cerebrospinal fluid tau protein and Alzheimer's disease severity.